Results 71 to 80 of about 1,351,031 (350)

Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study

Frontiers in Public Health
IntroductionThe Russian invasion of Ukraine displaced over 14 million people. By 2024, around 6 million Ukrainian refugees settled in Europe under the EU Temporary Protection Directive, providing permit of residence, work and health care.
Przemyslaw Kardas, Iryna Mogilevkina, Iryna Mogilevkina, Nilay Aksoy, Tamas Ágh, Tamas Ágh, Kristina Garuoliene, Marta Lomnytska, Natalja Istomina, Rita Urbanaviče, Björn Wettermark, Björn Wettermark, Nataliia Khanyk, Nataliia Khanyk   +13 more
doaj   +1 more source

The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: a systematic review

Patient Preference and Adherence, 2019
Background Patients’ adherence to therapeutic regimes may be influenced by subjective beliefs about chronic conditions. One of the challenges for health professionals in enhancing adherence is taking patients’ understanding into account when giving ...
Wejdan Shahin, G. Kennedy, I. Stupans
semanticscholar   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Factors Affecting Immunosuppressive Medication Adherence in Liver Transplant Recipients with Poor Adherence: A Qualitative Study

Patient Preference and Adherence, 2023
Zeliha Ozdemir Koken,1 Rana Elcin Sezer Ceren,1 Sabri Karahan,2 Osman Abbasoglu3 1Surgical Nursing Department, Hacettepe University Faculty of Nursing, Ankara, Turkiye; 2Surgical Nursing Department, Harran University, Faculty of Health Science, Sanliurfa,
Ozdemir Koken Z, Sezer Ceren RE, Karahan S, Abbasoglu O   +3 more
doaj  

Perspectives of older people with uncontrolled type 2 diabetes mellitus towards medication adherence: A qualitative study.

PLoS ONE, 2023
BackgroundBetter medication adherence among people with diabetes mellitus was found to be associated with improved glycaemic control. However, medication non-adherence is a significant concern in older people with uncontrolled type 2 diabetes mellitus ...
Sathma Upamali, Sarath Rathnayake
doaj   +1 more source

Navigating the Wild West of Medication Adherence Reporting in Specialty Pharmacy.

Journal of Managed Care & Specialty Pharmacy, 2019
Estimating medication adherence through the use of pharmacy claims-based adherence calculations such as medication possession ratio (MPR) and proportion of days covered (PDC) plays a significant role in specialty pharmacy practice.
Scott L Canfield, A. Zuckerman, R. Anguiano, J. Jolly, Joshua DeClercq, Molly Wascher, Leena Choi, S. Knox, David G Mitchell   +8 more
semanticscholar   +1 more source

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source

Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review

BMC Geriatrics, 2019
BackgroundPolypharmacy, and the associated adverse drug events such as non-adherence to prescriptions, is a common problem for elderly people living with multiple comorbidities. Deprescribing, i.e. the gradual withdrawal from medications with supervision
J. Ulley, D. Harrop, Ali N. Ali, S. Alton, Sally Fowler Davis   +4 more
semanticscholar   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source